LQDA
Price
$13.73
Change
+$0.05 (+0.37%)
Updated
Apr 17, 04:59 PM (EDT)
Capitalization
1.17B
21 days until earnings call
ROIV
Price
$10.15
Change
+$0.13 (+1.30%)
Updated
Apr 17, 04:59 PM (EDT)
Capitalization
7.15B
69 days until earnings call
Ad is loading...

LQDA vs ROIV

Header iconLQDA vs ROIV Comparison
Open Charts LQDA vs ROIVBanner chart's image
Liquidia
Price$13.73
Change+$0.05 (+0.37%)
Volume$11.21K
Capitalization1.17B
Roivant Sciences
Price$10.15
Change+$0.13 (+1.30%)
Volume$364.93K
Capitalization7.15B
LQDA vs ROIV Comparison Chart
Loading...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LQDA vs. ROIV commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LQDA is a Hold and ROIV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (LQDA: $13.68 vs. ROIV: $10.02)
Brand notoriety: LQDA and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LQDA: 69% vs. ROIV: 70%
Market capitalization -- LQDA: $1.17B vs. ROIV: $7.15B
LQDA [@Biotechnology] is valued at $1.17B. ROIV’s [@Biotechnology] market capitalization is $7.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $287.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LQDA’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • LQDA’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, both LQDA and ROIV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LQDA’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • LQDA’s TA Score: 4 bullish, 6 bearish.
  • ROIV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than LQDA.

Price Growth

LQDA (@Biotechnology) experienced а +7.13% price change this week, while ROIV (@Biotechnology) price change was +1.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -13.37%, and the average quarterly price growth was -24.84%.

Reported Earning Dates

LQDA is expected to report earnings on Aug 07, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.15B) has a higher market cap than LQDA($1.17B). LQDA YTD gains are higher at: 16.327 vs. ROIV (-15.300). ROIV has higher annual earnings (EBITDA): 4.1B vs. LQDA (-115.71M). ROIV has more cash in the bank: 5.15B vs. LQDA (176M). ROIV has less debt than LQDA: ROIV (100M) vs LQDA (122M). ROIV has higher revenues than LQDA: ROIV (123M) vs LQDA (14M).
LQDAROIVLQDA / ROIV
Capitalization1.17B7.15B16%
EBITDA-115.71M4.1B-3%
Gain YTD16.327-15.300-107%
P/E RatioN/A1.97-
Revenue14M123M11%
Total Cash176M5.15B3%
Total Debt122M100M122%
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
36
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LQDAROIV
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X84033.870000364.875000
+0.44%
Bitcoin cryptocurrency
GME26.25-0.45
-1.69%
GameStop Corp
SPY525.66-11.95
-2.22%
SPDR® S&P 500® ETF
AAPL194.27-7.87
-3.89%
Apple
TSLA241.55-12.56
-4.94%
Tesla

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with MTVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
+0.59%
MTVA - LQDA
44%
Loosely correlated
-9.35%
XERS - LQDA
35%
Loosely correlated
-6.85%
ROIV - LQDA
30%
Poorly correlated
-0.40%
ELVN - LQDA
30%
Poorly correlated
-5.75%
RARE - LQDA
30%
Poorly correlated
-1.02%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-0.40%
IMVT - ROIV
59%
Loosely correlated
-4.04%
ACLX - ROIV
52%
Loosely correlated
-1.20%
RCKT - ROIV
50%
Loosely correlated
-5.82%
DYN - ROIV
49%
Loosely correlated
-0.25%
KYMR - ROIV
49%
Loosely correlated
-1.73%
More